Inhalation Anaesthesia and Endocrine Disease

  • St. Jeretin
Part of the Anaesthesiology and Intensive Care Medicine / Anaesthesiologie und Intensivmedizin book series (A+I)


The number of surgical patients with endocrine disease is increasing. There are more and more patients being admitted for surgery on the endocrine glands, and even more patients with accompanying endocrine disorders or receiving hormonal therapy unconnected with the planned surgical procedure [20].


Anaesthetic Agent Ketone Body Regular Insulin Endocrine Disease Endocrine Gland 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Brown PS, Clark CG, Crooks J, Elston RC, Parbrook ED, Torburn AR (1964) Thyroid and adrenocortical responses to surgical operation. Clin Sci 27:447–452.PubMedGoogle Scholar
  2. 2.
    Cecat P, Proye C, Sonnenfeld H et al. (1979) Haemodynamic aspects of pheochromocytomas during operative period in patients under alpha adrenergic block. Lille Chir 34:8–12.Google Scholar
  3. 3.
    Clements RS (1972) The role of hyperglycaemia in the development of diabetic complications. Pfizer Laboratories Division Publications.Google Scholar
  4. 4.
    Cooperman LH, Engelman K, Mann PEG (1967) Anaesthetic management of pheochromocytoma employing halothane and adrenergic blockade. Anaesthesiology 28:575–581.Google Scholar
  5. 5.
    De Groot LJ (1965) Current views on formation of thyroid hormones. N Engl J Med 272:243–248.CrossRefGoogle Scholar
  6. 6.
    Desmonds JM, Le Hoveleur J, Remond P, Duvaldestin P (1977) Anaesthetic management of patients with pheochromocytoma, a review of 102 cases. Br J Anaesth 49:991–998.CrossRefGoogle Scholar
  7. 7.
    Engelbrecht ER, Hugill JT, Graves HB (1966) Anaesthetic management of pheochromocytoma. Can Anaesth Soc J 13:598–603.PubMedCrossRefGoogle Scholar
  8. 8.
    Goldman L, Greenspan FS (1965) Applied physiology of the thyroid and parathyroid glands. Surg Clin N Am 45:313–318.Google Scholar
  9. 9.
    Goichoechea JM (1975) Anaesthesia and reanimation in thyroid and parathyroid surgery. In: Aris A et al. Excerpta medica. American Elsevier, Amsterdam Oxford New York, pp 339–343.Google Scholar
  10. 10.
    Gravina E, Gravina Sanvitale G (1969) Effect of carnitine on blood acetoacetate in fasting children. Clin Chim Acta 23:376–377.PubMedCrossRefGoogle Scholar
  11. 11.
    Humble RM (1967) Pheochromocytoma, neurofibromatosis and pregnancy. Anaesthesia 22:296–299.PubMedCrossRefGoogle Scholar
  12. 12.
    Janeczko GF, Ivankovich AD, Glisson SN et al. (1977) Enflurane anaesthesia for surgical removal of pheochromocytoma. Curr Res Anaesth Analg 51/1:62–77.Google Scholar
  13. 13.
    Jeretin S (1979) Erfahrungen mit Silbersulfadiazine in der Vorbeugung und Therapie von Infektionen in der Intensivtherapie. Hyg Med 4:24–25.Google Scholar
  14. 14.
    Jeretin S, Music B (1980) The role of carnitine in total parenteral nutrition. Abstr 7th World Congr Anaesthesiologists, Hamburg 1980, Abstr No. 458, 238.Google Scholar
  15. 15.
    Katano K, Morisawa N, Obi M et al. (1978) The anaesthesia for pheochromocytoma. J Saitama Med School 4/3:443–446.Google Scholar
  16. 16.
    Katz J, Kadis LB (1973) Anaesthesia and uncommon disease. Saunders, Philadelphia London Toronto.Google Scholar
  17. 17.
    Lavine MH, Stopjack JC, Jerrold TL (1968) An adrenal crisis secondary to extraction of a tooth in a patient with panhypopituitarism. J Am Dent Assoc 76:354–356.Google Scholar
  18. 18.
    Oyama T (1971) Plasma levels of antidiuretic hormone in man during halothane anaesthesia and surgery. The year book of anaesthesia 1971. Year Book Medical Publishers, Chicago, pp 50–52.Google Scholar
  19. 19.
    Oyama T (1973) Anaesthetic management of endocrine disease. Springer, Berlin Heidelberg New York.CrossRefGoogle Scholar
  20. 20.
    Pender JW, Fox M, Basso LV (1973) Diseases of the endocrine system. In: Katz RL, Kadis LB (eds) Anaesthesia in incommon disease. Saunders, Philadelphia London Toronto, pp 121–127.Google Scholar
  21. 21.
    Raskin P, Unger R (1978) Hypoglycaemia and its suppression. N Engl J Med 299:433–436.PubMedCrossRefGoogle Scholar
  22. 22.
    Rollason WN (1964) Halothane and pheochromocytoma. Br J Anaesth 36:251–255.PubMedCrossRefGoogle Scholar
  23. 23.
    Stringel G, Ein SH, Creighton R et al. (1980) Pheochromocytoma in children — an update. J Pediatr Surg 15/4:496–500.CrossRefGoogle Scholar
  24. 24.
    Schultis K (1976) Postagressionsstoffwechsel als Adaptation und Krankheit. In: Heberer G, Schultis K, Hoffmann K (eds) Postaggressionsstoffwechsel, vol 3. Schattauer, Stuttgart New York.Google Scholar
  25. 25.
    Shimasoto S (1978) Altered cardiac performance to general volatile anaesthetics in health and disease. In: Haemodynamic changes in anaesthesia, tome 2,5th European congress of anaesthesiology, Paris 1978. Excerpta medica, Amsterdam Oxford, pp 1019–1036.Google Scholar
  26. 26.
    Wahren J, Felig P (1976) Influence of somatostatin on carbohydrate disposal and absorption in diabetes mellitus. Lancet 1213-1216.Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1982

Authors and Affiliations

  • St. Jeretin

There are no affiliations available

Personalised recommendations